Craft

Lexaria Bioscience Corp.

Stock Price

$2.4

2024-10-29

Market Capitalization

$41.2 M

2024-10-29

Revenue

$705.9 K

FY, 2025

Lexaria Bioscience Corp. Summary

Company Summary

Overview
Lexaria Bioscience Corp. becomes a revenue-generating biosciences company focused on proprietary technology for improved delivery of bioactive compounds including cannabinoids, through delicious foods. In 2014 the Company identified scientifically modulated hemp oil delivery as an area of wonderful potential for the Company and its shareholders. Today, Lexaria Bioscience Corp. is actively developing and selling hemp oil-based gourmet food products through its subsidiary ViPova and under the Lexaria Energy brand.
Type
Public
Status
Active
HQ
Kelowna, CA | view all locations
Website
https://www.lexariabioscience.com/
Cybersecurity rating
Sectors

Key People

  • Chris Bunka

    Chris Bunka, Chairman & CEO

    • John Docherty

      John Docherty, President and Director

      • Nicholas Baxter

        Nicholas Baxter, Director

        • Gregory Downey, Chief Financial Officer

          LocationsView all

          1 location detected

          • Kelowna, BC HQ

            Canada

            740 McCurdy Rd #100

          Lexaria Bioscience Corp. Financials

          Summary Financials

          Revenue (Q2, 2026)
          $20.0K
          Gross profit (Q2, 2026)
          $20.0K
          Net income (Q2, 2026)
          ($1.5M)
          Cash (Q2, 2026)
          $5.1M
          EBIT (Q2, 2026)
          ($1.5M)
          Enterprise value
          $36.2M

          Footer menu